Evaluation of serum IL-6 and fecal calprotectin in covid-19 positive patients with GIT symptoms as markers of intestinal inflammation
The Egyptian journal of Immunology · 01.07.2026 · 33 (3) · 82-94
DOI: 10.55133/eji.330309 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian journal of Immunology, online erschienen am 01.07.2026. Verfasst von Mohamed N B Alashram und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Hepatogastroenterology, Faculty of Medicine, Ain Shams University, Egypt. Hauptthemen laut MEDLINE: Interleukin-6, Leukocyte L1 Antigen Complex, Feces, COVID-19.
Abstract (Originalsprache)
Generally, people who acquire infection with the COVID-19 virus exhibit a fever and respiratory illness. However, certain individuals also exhibit gastrointestinal (GIT) symptoms, involving anorexia, diarrhea, abdominal pain, nausea, and vomiting. This study aimed to quantify and assess serum interleukin 6 (IL-6) and fecal calprotectin (FC) in COVID-19-positive individuals who exhibit diarrhea and other GIT symptoms as indicators of inflammation in the intestinal tract. The investigation included 80 cases with diarrhea and other GIT symptoms. They were divided into two groups: group A (cases) consisted of 40 COVID-19 patients with GIT symptoms and group B (controls) consisted of 40 COVID-19 patients without GIT symptoms. Serum IL-6 and FC were assessed in both groups. The most effective cut-off value for predicting intestinal inflammation was >63, with a sensitivity of 67.5% and a specificity of 65%. The most effective cut-off value for predicting intestinal inflammation was >194, with a sensitivity of 87.6% and a specificity of 77.3%. Although the FC was more significant than serum IL-6, the difference in the area under curve (AUC) was insignificant (0.075; z-test= 1.632, p>0.05). In COVID-19 cases with experienced intestinal symptoms, serum IL-6 and FC were increased.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Hepatogastroenterology, Faculty of Medicine, Ain Shams University, Egypt.
Zitieren
APA
Alashram, M. N. B., Alrefaey, A. A., El Nakeeb, N. A., Khyal, A. E., Ahmed, A. E., & Guirguis, R. N. M. (2026). Evaluation of serum IL-6 and fecal calprotectin in covid-19 positive patients with GIT symptoms as markers of intestinal inflammation. The Egyptian journal of Immunology, 33(3), 82-94. https://doi.org/10.55133/eji.330309
Vancouver
Alashram MNB, Alrefaey AA, El Nakeeb NA, Khyal AE, Ahmed AE, Guirguis RNM. Evaluation of serum IL-6 and fecal calprotectin in covid-19 positive patients with GIT symptoms as markers of intestinal inflammation. The Egyptian journal of Immunology. 2026;33(3):82-94. doi:10.55133/eji.330309
BibTeX
@article{Alashram2026,
author = {Alashram, Mohamed N B and Alrefaey, Alsaied A and El Nakeeb, Noah A and Khyal, Ahmed E and Ahmed, Ahmed E and Guirguis, Reginia N M},
title = {Evaluation of serum IL-6 and fecal calprotectin in covid-19 positive patients with GIT symptoms as markers of intestinal inflammation},
journal = {The Egyptian journal of Immunology},
year = {2026},
volume = {33},
number = {3},
pages = {82--94},
doi = {10.55133/eji.330309}
}
EUVIMED